Externally applied medicine for treating leucoderma

A topical medicine, vitiligo technology, applied in the field of topical medicines for treating vitiligo

Inactive Publication Date: 2013-04-17
WEIFANG SHENGREN PHARMA
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Western medicine theory emphasizes that vitiligo is the skin pigmentation loss caused by skin metabolism disorder, and there is no effective treatment method at present.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0010] Example, select: musk 10g, Angelica dahurica 25g, Shouwu vine 35g, safflower 24g, dragon tail 25g, white moss bark 55g, turnip 25g, red peony 18g, windproof 55g, Jiangzi 20g, myrrh 24g, Lingxiaohua 18g.

[0011] Take the medicinal materials in the above parts by weight, concentrate, mix and pulverize them through a 40-60 mesh sieve to obtain a granular shape, use 2-2.5 times the 65-70° white wine of the above-mentioned medicine, soak at room temperature for 7-13 days, and then use 2- 5 layers of gauze filter residue to obtain the liquid medicine, and then apply the liquid medicine to the affected part.

[0012] The medicinal liquid provided by the present invention has a short treatment time and quick effect on vitiligo, and the general patients can see the effect after taking the medicine for about 10 days. It can be cured within one month, and the cure rate for various patients can be more than 85%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses externally applied medicine for treating leucoderma, which comprises the following active ingredients by weight: 10 g musk, 25 g radix angelicae, 35 g vines of multiflower knotweed, 24 g carthamus tinctorius, 25 g cantharides, 55 g dittany bark, 25 g brassica rapa, 18 g radix paeoniae rubra, 55 g radix saposhnikoviae, 20 g croton, 24 g myrrh and 18 g campsis grandiflora. The liquid medicine has a short treat period for the leucoderma, takes effect rapidly, and can take effect when a patient takes the medicine for approximately 10 days generally. The leucoderma can be cured within a month, and the cure rate for various patients can be over 85%.

Description

technical field [0001] The invention relates to a medicine for external use for treating vitiligo and belongs to the technical field of traditional Chinese medicines. Background technique [0002] my country's traditional Chinese medicine theory believes that the pathogenesis of vitiligo is the result of the interaction of internal and external factors in the body. Internal causes of deficiency of the liver, spleen and kidney, mostly caused by deficiency of liver blood, deficiency of kidney yang, and deficiency of kidney qi, lead to an imbalance of yin and yang in the body, and imbalance of qi and blood. On this basis, damp-heat and wind evils take advantage of the emptiness and enter the skin, blocking the meridians and blood vessels. White erosion or white barge wind. The principle of treatment is to nourish blood and dispel wind, promote blood circulation and remove blood stasis. The medicines are Chinese patent medicines such as Vitiligo Pills, Baicei Pills, and Vitili...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/75A61P17/00A61K35/55
Inventor 李明伟
Owner WEIFANG SHENGREN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap